NIH head mulls royalties for drugmakers; PACS systems for cardiology?;

> Think the pharmas will like this proposal? The new head of NIH is considering plans to charge royalty fees to pharmas whose drug discoveries piggyback off of federally-supported research. FiercePharma

> Picture archiving and communications systems (PACS) are very popular, but most are used primarily in radiology. Now, advocates are suggesting that cardiology is another area ripe for PACS use. FierceHealthIT

> Workhorse diabetes drug metformin is proving to be a powerful weapon in the fight against cancer when combined with doxorubicin, a standard chemotherapy drug. FierceBiotechResearch

> Are you one of the skeptics worried that the current push to install EMRs can't possibly solve all of the industry's problems? You're not alone: Check out this week's Journal of the American Medical Association, which includes two articles taking that position. FierceEMR

And Finally... A once-mighty financial institution auctions off its multi-million-dollar art collection. Article